BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, Mccoll SR, Beard MR. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004;39:1220-9. [DOI: 10.1002/hep.20167] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Guo D, Zhao Y, Chen X, Ma L, Jin Y, Yan H, Wu H, Wei L, Dong T, Chen X. The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection. Antiviral Res 2011;92:247-54. [PMID: 21889543 DOI: 10.1016/j.antiviral.2011.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hajarizadeh B, Lamoury FM, Feld JJ, Amin J, Keoshkerian E, Matthews GV, Hellard M, Dore GJ, Lloyd AR, Grebely J, Applegate TL; ATAHC Study Group. Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection. Virol J 2016;13:32. [PMID: 26911712 DOI: 10.1186/s12985-016-0482-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hathaway-Schrader JD, Poulides NA, Carson MD, Kirkpatrick JE, Warner AJ, Swanson BA, Taylor EV, Chew ME, Reddy SV, Liu B, Westwater C, Novince CM. Specific Commensal Bacterium Critically Regulates Gut Microbiota Osteoimmunomodulatory Actions During Normal Postpubertal Skeletal Growth and Maturation. JBMR Plus 2020;4:e10338. [PMID: 32161843 DOI: 10.1002/jbm4.10338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Antonelli A, Fallahi P, Ferrari SM, Corrado A, Sebastiani M, Giuggioli D, Miccoli M, Zignego AL, Sansonno D, Marchi S, Ferri C. Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. Clin Rheumatol 2013;32:1147-54. [DOI: 10.1007/s10067-013-2246-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
6 Nelson GM, Padera TP, Garkavtsev I, Shioda T, Jain RK. Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia 2007;9:1038-45. [PMID: 18084611 DOI: 10.1593/neo.07643] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
7 Miller MB, Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009;22:611-33. [PMID: 19822891 DOI: 10.1128/CMR.00019-09] [Cited by in Crossref: 257] [Cited by in F6Publishing: 66] [Article Influence: 21.4] [Reference Citation Analysis]
8 Zhou JY, Song LW, Yuan R, Lu XP, Wang GQ. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm. World J Gastroenterol 2021; 27(21): 2910-2920 [PMID: 34135561 DOI: 10.3748/wjg.v27.i21.2910] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol. 2005;167:887-899. [PMID: 16127166 DOI: 10.1016/s0002-9440(10)62060-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
10 Martrus G, Kautz T, Lunemann S, Richert L, Glau L, Salzberger W, Goebels H, Langeneckert A, Hess L, Poch T, Schramm C, Oldhafer KJ, Koch M, Tolosa E, Nashan B, Altfeld M. Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells. PLoS One 2017;12:e0182532. [PMID: 28792982 DOI: 10.1371/journal.pone.0182532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
11 Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 2005;106:1175-82. [PMID: 15860662 DOI: 10.1182/blood-2005-01-0126] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 7.6] [Reference Citation Analysis]
12 Zhang R, Shao C, Huo N, Li M, Xu X. Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China. Gut Liver 2016;10:446-55. [PMID: 26470765 DOI: 10.5009/gnl15162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Wald O, Weiss ID, Galun E, Peled A. Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics. Cytokine 2007;39:50-62. [DOI: 10.1016/j.cyto.2007.05.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
14 Qi Z, Wang J, Han X, Yang J, Zhao G, Cao Y. Listr1 locus regulates innate immunity against Listeria monocytogenes infection in the mouse liver possibly through Cxcl11 polymorphism. Immunogenetics 2014;66:231-42. [PMID: 24566892 DOI: 10.1007/s00251-014-0761-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Shin SY, Jeong SH, Sung PS, Lee J, Kim HJ, Lee HW, Shin EC. Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B. Yonsei Med J 2016;57:652-7. [PMID: 26996565 DOI: 10.3349/ymj.2016.57.3.652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(47): 7149-7159 [PMID: 19084927 DOI: 10.3748/wjg.14.7149] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
18 Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol. 2009;31:309-322. [PMID: 19533132 DOI: 10.1007/s00281-009-0167-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
19 Sung PS, Hong SH, Lee J, Park SH, Yoon SK, Chung WJ, Shin EC. CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner. Sci Rep 2017;7:6387. [PMID: 28744018 DOI: 10.1038/s41598-017-06784-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
20 Lanford RE, Guerra B, Lee H. Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain. Virology 2006;355:192-202. [DOI: 10.1016/j.virol.2006.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
21 Fahey S, Dempsey E, Long A. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol 2014;11:25-40. [PMID: 23954947 DOI: 10.1038/cmi.2013.37] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
22 Zhang JY, Qu F, Li JF, Liu M, Ren F, Zhang JY, Bian DD, Chen Y, Duan ZP, Zhang JL, Zheng SJ. Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study. Medicine (Baltimore) 2016;95:e3773. [PMID: 27281078 DOI: 10.1097/MD.0000000000003773] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ding CB, Zhang JP, Zhao Y, Peng ZG, Song DQ, Jiang JD. Zebrafish as a potential model organism for drug test against hepatitis C virus. PLoS One. 2011;6:e22921. [PMID: 21857967 DOI: 10.1371/journal.pone.0022921] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
24 Kang W, Shin EC. Clinical implications of chemokines in acute and chronic hepatitis C virus infection. Yonsei Med J 2011;52:871-8. [PMID: 22028149 DOI: 10.3349/ymj.2011.52.6.871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
25 Sun J, Li K, Shata MT, Chan TS. The immunologic basis for hepatitis C infection. Curr Opin Gastroenterol. 2004;20:598-602. [PMID: 15703689 DOI: 10.1097/00001574-200411000-00016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
26 Maire M, Parent R, Morand AL, Alotte C, Trépo C, Durantel D, Petit MA. Characterization of the double-stranded RNA responses in human liver progenitor cells. Biochem Biophys Res Commun 2008;368:556-62. [PMID: 18258184 DOI: 10.1016/j.bbrc.2008.01.123] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
27 Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D’Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA. 2005;102:18544-18549. [PMID: 16339892 DOI: 10.1073/pnas.0509402102] [Cited by in Crossref: 203] [Cited by in F6Publishing: 186] [Article Influence: 11.9] [Reference Citation Analysis]
28 Antonelli A, Ferri C, Ferrari SM, Ruffilli I, Colaci M, Frascerra S, Miccoli M, Franzoni F, Galetta F, Fallahi P. High Serum Levels of CXCL11 in Mixed Cryoglobulinemia Are Associated with Increased Circulating Levels of Interferon-γ. J Rheumatol 2011;38:1947-52. [DOI: 10.3899/jrheum.110133] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
29 Manickam C, Rajakumar P, Wachtman L, Kramer JA, Martinot AJ, Varner V, Giavedoni LD, Reeves RK. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol 2016;90:9153-62. [PMID: 27489267 DOI: 10.1128/JVI.01051-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
30 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Larrubia J, Calvino M, Benito S, Sanz-de-villalobos E, Perna C, Pérez-hornedo J, González-mateos F, García-garzón S, Bienvenido A, Parra T. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. Journal of Hepatology 2007;47:632-41. [DOI: 10.1016/j.jhep.2007.04.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
32 Wang Y, Yu W, Shen C, Wang W, Zhang L, Liu F, Sun H, Zhao Y, Che H, Zhao C. Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients. Sci Rep 2017;7:40404. [PMID: 28067328 DOI: 10.1038/srep40404] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
33 Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology. 2008;48:1440-1450. [PMID: 18798334 DOI: 10.1002/hep.22500] [Cited by in Crossref: 161] [Cited by in F6Publishing: 164] [Article Influence: 11.5] [Reference Citation Analysis]
34 Hoh BP, Umi-Shakina H, Zuraihan Z, Zaiharina MZ, Rafidah-Hanim S, Mahiran M, Khairudin NY, Benedict LH, Masliza Z, Christopher KC, Sazaly AB. Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia. Hum Immunol 2015;76:421-6. [PMID: 25858769 DOI: 10.1016/j.humimm.2015.03.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
35 Perney P, Turriere C, Portalès P, Rigole H, Psomas C, Blanc F, Clot J, Corbeau P. CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C. Clinical Immunology 2009;132:55-62. [DOI: 10.1016/j.clim.2009.03.521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
36 Tse E, Helbig KJ, Van der Hoek K, McCartney EM, Van der Hoek M, George J, Beard MR. Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon. J Interferon Cytokine Res 2015;35:392-400. [PMID: 25588104 DOI: 10.1089/jir.2014.0165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
37 Chalin A, Lefevre B, Devisme C, Barget N, Amiot L, Samson M. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection. Cytokine 2019;117:72-8. [PMID: 30826602 DOI: 10.1016/j.cyto.2019.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
38 Helbig KJ, George J, Beard MR. A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro. J Clin Virol 2005;32:137-43. [PMID: 15653416 DOI: 10.1016/j.jcv.2004.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
39 Chen Y, Zhou S, Jiang Z, Wang X, Liu Y. Chemokine receptor CXCR3 in turbot (Scophthalmus maximus): cloning, characterization and its responses to lipopolysaccharide. Fish Physiol Biochem 2016;42:659-71. [DOI: 10.1007/s10695-015-0167-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
40 Lanford RE, Guerra B, Lee H, Chavez D, Brasky KM, Bigger CB. Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 2006;43:961-72. [PMID: 16628626 DOI: 10.1002/hep.21167] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
41 Brass A, Brenndörfer ED. The role of chemokines in hepatitis C virus-mediated liver disease. Int J Mol Sci. 2014;15:4747-4779. [PMID: 24646914 DOI: 10.3390/ijms15034747] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
42 Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol 2009;83:836-46. [PMID: 18987152 DOI: 10.1128/JVI.01388-08] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
43 Walker JP, Bumgardner GL. Hepatocyte immunology and transplantation: current status and future potential: . Current Opinion in Organ Transplantation 2005;10:67-76. [DOI: 10.1097/01.mot.0000163353.27564.42] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Antonelli A, Fallahi P, Ferrari S, Frascerra S, Mancusi C, Colaci M, Manfredi A, Sansonno D, Zignego A, Ferri C. High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia. Int J Immunopathol Pharmacol 2013;26:49-57. [DOI: 10.1177/039463201302600105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
45 Liang CM, Chen L, Hu H, Ma HY, Gao LL, Qin J, Zhong CP. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World J Hepatol 2015; 7(10): 1390-1402 [PMID: 26052384 DOI: 10.4254/wjh.v7.i10.1390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
46 Crawford JM, Burt AD. Anatomy, pathophysiology and basic mechanisms of disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 1-77. [DOI: 10.1016/b978-0-7020-3398-8.00001-5] [Cited by in Crossref: 11] [Article Influence: 1.1] [Reference Citation Analysis]
47 Narayana SK, Helbig KJ, McCartney EM, Eyre NS, Bull RA, Eltahla A, Lloyd AR, Beard MR. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry. J Biol Chem 2015;290:25946-59. [PMID: 26354436 DOI: 10.1074/jbc.M115.657346] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 10.1] [Reference Citation Analysis]
48 Cruise MW, Lukens JR, Nguyen AP, Lassen MG, Waggoner SN, Hahn YS. Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. J Immunol. 2006;176:6235-6244. [PMID: 16670334 DOI: 10.4049/jimmunol.176.10.6235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
49 Oo YH, Shetty S, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis. 2010;28:31-44. [PMID: 20460888 DOI: 10.1159/000282062] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
50 Zhang W, Fei Y, Gao J, Liu B, Zhang F. The role of CXCR3 in the induction of primary biliary cirrhosis. Clin Dev Immunol. 2011;2011:564062. [PMID: 21647407 DOI: 10.1155/2011/564062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
51 Harris DP, Chandrasekharan UM, Bandyopadhyay S, Willard B, DiCorleto PE. PRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ Costimulation. PLoS One 2016;11:e0148905. [PMID: 26901772 DOI: 10.1371/journal.pone.0148905] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zekry A. Cytokines and liver injury in chronic HCV genotype 4 infection. Journal of Gastroenterology and Hepatology 2009;24:332-5. [DOI: 10.1111/j.1440-1746.2009.05815.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(11): 2664-2667 [DOI: 10.11569/wcjd.v12.i11.2664] [Reference Citation Analysis]
54 Abe T, Fukuhara T, Wen X, Ninomiya A, Moriishi K, Maehara Y, Takeuchi O, Kawai T, Akira S, Matsuura Y. CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan. J Virol. 2012;86:6159-6170. [PMID: 22491449 DOI: 10.1128/jvi.06872-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
55 Larrubia JR, Moreno-Cubero E, Lokhande MU, García-Garzón S, Lázaro A, Miquel J, Perna C, Sanz-de-Villalobos E. Adaptive immune response during hepatitis C virus infection. World J Gastroenterol 2014; 20(13): 3418-3430 [PMID: 24707125 DOI: 10.3748/wjg.v20.i13.3418] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
56 Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM, Lanford RE. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004;78:13779-92. [PMID: 15564486 DOI: 10.1128/JVI.78.24.13779-13792.2004] [Cited by in Crossref: 204] [Cited by in F6Publishing: 119] [Article Influence: 11.3] [Reference Citation Analysis]
57 Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology. 2006;349:347-358. [PMID: 16545852 DOI: 10.1016/j.virol.2006.02.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
58 Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, Thantiworasit P, Wightman F, Locarnini S, Matthews G, Dore GJ, Ruxrungtham K, Lewin SR. No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy. J Virol 2010;84:2657-65. [PMID: 20053751 DOI: 10.1128/JVI.02124-09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
59 Roberts LR. Chemokines as Attractive Targets in Liver Carcinogenesis. Am J Gastroenterology 2005;100:499-501. [DOI: 10.1111/j.1572-0241.2005.t01-4-41219.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
60 Berres ML, Lehmann J, Jansen C, Görtzen J, Meyer C, Thomas D, Zimmermann HW, Kroy D, Schumacher F, Strassburg CP, Sauerbruch T, Trautwein C, Wasmuth HE, Trebicka J. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Liver Int 2016;36:386-94. [PMID: 26212075 DOI: 10.1111/liv.12922] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
61 Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA, Lloyd AR, Jaworowski A, French MA, Lewin SR. HIV and co-infections. Immunol Rev 2013;254:114-42. [PMID: 23772618 DOI: 10.1111/imr.12063] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
62 McCartney EM, Helbig KJ, Narayana SK, Eyre NS, Aloia AL, Beard MR. Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology. 2013;58:1558-1568. [PMID: 23703790 DOI: 10.1002/hep.26496] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
63 Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. J Hepatol. 2015;62:332-339. [PMID: 25457205 DOI: 10.1016/j.jhep.2014.09.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
64 Pineda-Tenor D, Berenguer J, García-Álvarez M, Guzmán-Fulgencio M, Carrero A, Aldámiz-Echevarria T, Tejerina F, Diez C, Jiménez-Sousa MA, Fernández-Rodríguez A, Munoz-Fernandez MA, Resino S. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr 2015;68:386-95. [PMID: 25559603 DOI: 10.1097/QAI.0000000000000491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
65 McCartney EM, Semendric L, Helbig KJ, Hinze S, Jones B, Weinman SA, Beard MR. Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. J Infect Dis. 2008;198:1766-1775. [PMID: 18956976 DOI: 10.1086/593216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
66 Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation. World J Gastroenterol 2014; 20(36): 13088-13104 [PMID: 25278703 DOI: 10.3748/wjg.v20.i36.13088] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
67 Zhang S, Zhao Y, Yan H, Wu H, Wei L, Zhang Y, Chen X. Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection. Int J Infect Dis 2015;33:15-21. [PMID: 25461236 DOI: 10.1016/j.ijid.2014.08.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
68 Antonelli A, Fallahi P, Ferrari SM, Sebastiani M, Manfredi A, Mazzi V, Fabiani S, Centanni M, Marchi S, Ferri C. Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. Modern Rheumatology 2014;22:659-67. [DOI: 10.3109/s10165-011-0565-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
69 Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S. CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 2015;26:311-27. [DOI: 10.1016/j.cytogfr.2014.11.009] [Cited by in Crossref: 156] [Cited by in F6Publishing: 147] [Article Influence: 22.3] [Reference Citation Analysis]
70 Zhang Y, Zhao W, Li S, Lv M, Yang X, Li M, Zhang Z. CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling. Cancer Lett 2019;449:163-71. [PMID: 30771435 DOI: 10.1016/j.canlet.2019.02.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
71 Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005;42:702-710. [PMID: 16108059 DOI: 10.1002/hep.20844] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 10.6] [Reference Citation Analysis]
72 Knapp S, Meghjee N, Cassidy S, Jamil K, Thursz M. Detection of allele specific differences in IFNL3 (IL28B) mRNA expression. BMC Med Genet. 2014;15:104. [PMID: 25287681 DOI: 10.1186/s12881-014-0104-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, McCartney EM, Jangra RK, Lemon SM, Beard MR. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 2011;54:1506-17. [PMID: 22045669 DOI: 10.1002/hep.24542] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 14.9] [Reference Citation Analysis]
74 Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis 2021;12:260. [PMID: 33707417 DOI: 10.1038/s41419-021-03545-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Monnier J, Boissan M, L’Helgoualc’h A, Lacombe ML, Turlin B, Zucman-Rossi J, Théret N, Piquet-Pellorce C, Samson M. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer. 2012;48:138-148. [PMID: 21778049 DOI: 10.1016/j.ejca.2011.06.044] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
76 Johansson S, Talloen W, Tuefferd M, Darling J, Fanning G, Fried MW, Aerssens J. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity. Liver Int 2016;36:344-52. [PMID: 26344576 DOI: 10.1111/liv.12932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Liu JQ, Chu SF, Zhou X, Zhang DY, Chen NH. Role of chemokines in Parkinson's disease. Brain Res Bull 2019;152:11-8. [PMID: 31136787 DOI: 10.1016/j.brainresbull.2019.05.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
78 Eisenhardt M, Glässner A, Krämer B, Körner C, Sibbing B, Kokordelis P, Nischalke HD, Sauerbruch T, Spengler U, Nattermann J. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS One. 2012;7:e38846. [PMID: 22792160 DOI: 10.1371/journal.pone.0038846] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
79 Nguyen N, de Esch C, Cameron B, Kumar RK, Zekry A, Lloyd AR. Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression. J Gastroenterol Hepatol 2014;29:860-9. [PMID: 24236853 DOI: 10.1111/jgh.12462] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
80 Gorrell MD, Zekry A, Mccaughan GW, Lloyd A, Kowdley K, Mccaughan G, Trautwein C. The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection. Hepatology 2011;54:1875-9. [DOI: 10.1002/hep.24600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
81 Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol. 2008;14:7149-7159. [PMID: 19084927 DOI: 10.3748/wjg.14.7149.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Sun R, Park O, Horiguchi N, Kulkarni S, Jeong WI, Sun HY, Radaeva S, Gao B. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology. 2006;44:955-966. [PMID: 17006930 DOI: 10.1002/hep.21344] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
83 Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 2007;0:070124051929001-???. [DOI: 10.1111/j.1365-2893.2006.00838.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 77] [Article Influence: 0.9] [Reference Citation Analysis]
84 Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, Chin KC, Aw P, George J, Kuznetsov VA, Schreiber M, Vasudevan SG, Hibberd ML. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 2007;1:e86. [PMID: 18060089 DOI: 10.1371/journal.pntd.0000086] [Cited by in Crossref: 164] [Cited by in F6Publishing: 155] [Article Influence: 10.9] [Reference Citation Analysis]
85 Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, Major M, Veerapu NS, Heller T, Feinstone SM, Rice CM, Rehermann B. Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C. Gastroenterology 2011;141:686-95, 695.e1. [PMID: 21699897 DOI: 10.1053/j.gastro.2011.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
86 Ishii S, Koziel MJ. Immune responses during acute and chronic infection with hepatitis C virus. Clin Immunol. 2008;128:133-147. [PMID: 18514579 DOI: 10.1016/j.clim.2008.03.525] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
87 Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology. 2009;49:676-688. [PMID: 19177577 DOI: 10.1002/hep.22763] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 7.4] [Reference Citation Analysis]
88 Chalin A, Lefevre B, Devisme C, Pronier C, Carrière V, Thibault V, Amiot L, Samson M. Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury. Cytokine 2018;111:500-4. [DOI: 10.1016/j.cyto.2018.05.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]